 | • レポートコード：QYR9ST03694 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、次世代の糖尿病治療及びドラッグデリバリーの世界市場について調査・分析し、次世代の糖尿病治療及びドラッグデリバリーの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（吸入インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓）、用途別（診断/診療所、ICU、在宅医療）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の次世代の糖尿病治療及びドラッグデリバリー市場動向 ・主要企業別マーケットシェア ・次世代の糖尿病治療及びドラッグデリバリーの種類別市場規模2014-2019 （吸入インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓） ・次世代の糖尿病治療及びドラッグデリバリーの用途別市場規模2014-2019 （診断/診療所、ICU、在宅医療） ・次世代の糖尿病治療及びドラッグデリバリーの北米市場：主要企業・種類別/用途別市場規模 ・次世代の糖尿病治療及びドラッグデリバリーのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・次世代の糖尿病治療及びドラッグデリバリーの中国市場：主要企業・種類別/用途別市場規模 ・次世代の糖尿病治療及びドラッグデリバリーの日本国内市場：主要企業・種類別/用途別市場規模 ・次世代の糖尿病治療及びドラッグデリバリーの東南アジア市場：主要企業・種類別/用途別市場規模 ・次世代の糖尿病治療及びドラッグデリバリーのインド市場：主要企業・種類別/用途別市場規模 ・次世代の糖尿病治療及びドラッグデリバリーの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Johnson & Johnson、Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind Corporation、Enteris BioPharma、Dexcom、Senseonics、Medtech、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly and Company、Transdermal Specialties） ・次世代の糖尿病治療及びドラッグデリバリーの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.
Asia-Pacific possesses high market potential for the growth of next generation diabetes therapy and drug delivery market, owing to increase in demand for advanced diabetic products, high incidence of diabetes, and rise in healthcare expenditure. It has experienced fast-paced growth, in terms of production and development of advanced diabetic products.
In 2018, the global Next Generation Diabetes Therapy and Drug Delivery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Next Generation Diabetes Therapy and Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Diabetes Therapy and Drug Delivery development in United States, Europe and China.
The key players covered in this study
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Market segment by Type, the product can be split into
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Market segment by Application, split into
Diagnostic/Clinics
ICUs
Home Healthcare
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Next Generation Diabetes Therapy and Drug Delivery status, future forecast, growth opportunity, key market and key players.
To present the Next Generation Diabetes Therapy and Drug Delivery development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Next Generation Diabetes Therapy and Drug Delivery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (2014-2025)
1.4.2 Inhalable Insulin
1.4.3 Oral Insulin
1.4.4 Insulin Patches
1.4.5 CGM Systems
1.4.6 Artificial Pancreas
1.5 Market by Application
1.5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2025)
1.5.2 Diagnostic/Clinics
1.5.3 ICUs
1.5.4 Home Healthcare
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size
2.2 Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Regions
2.2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions (2014-2025)
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Manufacturers
3.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Manufacturers (2014-2019)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.3 Key Players Next Generation Diabetes Therapy and Drug Delivery Product/Solution/Service
3.4 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019)
5 United States
5.1 United States Next Generation Diabetes Therapy and Drug Delivery Market Size (2014-2019)
5.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in United States
5.3 United States Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
5.4 United States Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
6 Europe
6.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2014-2019)
6.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Europe
6.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
6.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
7 China
7.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2014-2019)
7.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in China
7.3 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
7.4 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
8 Japan
8.1 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (2014-2019)
8.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Japan
8.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
8.4 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2014-2019)
9.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Southeast Asia
9.3 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
9.4 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
10 India
10.1 India Next Generation Diabetes Therapy and Drug Delivery Market Size (2014-2019)
10.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in India
10.3 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
10.4 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
11 Central & South America
11.1 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size (2014-2019)
11.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Central & South America
11.3 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
11.4 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.2.5 Abbott Laboratories Recent Development
12.3 Medtronic
12.3.1 Medtronic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.3.5 Medtronic Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Novo Nordisk
12.5.1 Novo Nordisk Company Details
12.5.2 Company Description and Business Overview
12.5.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.5.5 Novo Nordisk Recent Development
12.6 MannKind Corporation
12.6.1 MannKind Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.6.5 MannKind Corporation Recent Development
12.7 Enteris BioPharma
12.7.1 Enteris BioPharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.7.5 Enteris BioPharma Recent Development
12.8 Dexcom
12.8.1 Dexcom Company Details
12.8.2 Company Description and Business Overview
12.8.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.8.5 Dexcom Recent Development
12.9 Senseonics
12.9.1 Senseonics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.9.5 Senseonics Recent Development
12.10 Medtech
12.10.1 Medtech Company Details
12.10.2 Company Description and Business Overview
12.10.3 Next Generation Diabetes Therapy and Drug Delivery Introduction
12.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
12.10.5 Medtech Recent Development
12.11 Synertech
12.12 Zosano Pharma
12.13 Relmada Therapeutics
12.14 Eli Lilly and Company
12.15 Transdermal Specialties
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Next Generation Diabetes Therapy and Drug Delivery Key Market Segments
Table Key Players Next Generation Diabetes Therapy and Drug Delivery Covered
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type 2014-2025
Figure Inhalable Insulin Figures
Table Key Players of Inhalable Insulin
Figure Oral Insulin Figures
Table Key Players of Oral Insulin
Figure Insulin Patches Figures
Table Key Players of Insulin Patches
Figure CGM Systems Figures
Table Key Players of CGM Systems
Figure Artificial Pancreas Figures
Table Key Players of Artificial Pancreas
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth by Application 2014-2025 (Million US$)
Figure Diagnostic/Clinics Case Studies
Figure ICUs Case Studies
Figure Home Healthcare Case Studies
Figure Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2025 (Million US$)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions 2014-2025 (Million US$)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions 2014-2019 (Million US$)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions 2014-2019
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions 2014-2019
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions 2019
Table Market Top Trends
Table Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Manufacturers (2014-2019)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Manufacturers in 2018
Table Global Next Generation Diabetes Therapy and Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Next Generation Diabetes Therapy and Drug Delivery Product/Solution/Service
Table Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019) (Million US$)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type (2014-2019)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2014-2019)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Application (2014-2019)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Application (2014-2019)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application in 2018
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2019 (Million US$)
Table United States Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2018-2019) (Million US$)
Table United States Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2018-2019)
Table United States Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019) (Million US$)
Table United States Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2014-2019)
Table United States Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table United States Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2019)
Figure Europe Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2019 (Million US$)
Table Europe Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2018-2019) (Million US$)
Table Europe Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2018-2019)
Table Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019) (Million US$)
Table Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2014-2019)
Table Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2019)
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2019 (Million US$)
Table China Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2018-2019) (Million US$)
Table China Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2018-2019)
Table China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-20189) (Million US$)
Table China Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2014-2019)
Table China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table China Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2019)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2019 (Million US$)
Table Japan Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2018-2019) (Million US$)
Table Japan Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2018-2019)
Table Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019) (Million US$)
Table Japan Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2014-2019)
Table Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table Japan Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2019)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2018-2019)
Table Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2014-2019)
Table Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2019)
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2019 (Million US$)
Table India Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2018-2019) (Million US$)
Table India Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2018-2019)
Table India Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019) (Million US$)
Table India Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2014-2019)
Table India Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table India Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2019)
Figure Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2018-2019)
Table Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019) (Million US$)
Table Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2014-2019)
Table Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019) (Million US$)
Table Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2014-2019)
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019) (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Medtronic Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Sanofi Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Novo Nordisk Recent Development
Table MannKind Corporation Company Details
Table MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table MannKind Corporation Recent Development
Table Enteris BioPharma Company Details
Table Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Enteris BioPharma Recent Development
Table Dexcom Company Details
Table Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Dexcom Recent Development
Table Senseonics Company Details
Table Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Senseonics Recent Development
Table Medtech Company Details
Table Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)(Million US$)
Figure Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2014-2019)
Table Medtech Recent Development
Table Synertech Company Details
Table Zosano Pharma Company Details
Table Relmada Therapeutics Company Details
Table Eli Lilly and Company Company Details
Table Transdermal Specialties Company Details
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions (Million US$) 2019-2025
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Regions (2019-2025)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Regions in 2025
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2019-2025)(Million USD)
Figure Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2019-2025)(Million USD)
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2019-2025)(Million USD)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2019-2025)(Million USD)
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2019-2025)(Million USD)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Product (2019-2025) (Million US$)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Product (2019-2025)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Product in 2025
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2019-2025) (Million US$)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2019-2025)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の自動インスリン送達システム市場：専門的調査 The Automatic Insulin Delivery Systems, also known as artificial pancreas or hybrid closed loop automatically manages or withholds insulin in response to blood glucose measurements (via using continuous glucose monitors (CGMs) and smart algorithms).Asia-Pacific region is the largest and fastest-grow…- 世界の自動インスリン送達システム市場：専門的調査 The Automatic Insulin Delivery Systems, also known as artificial pancreas or hybrid closed loop automatically manages or withholds insulin in response to blood glucose measurements (via using continuous glucose monitors (CGMs) and smart algorithms).Asia-Pacific region is the largest and fastest-grow…
- 非インスリン糖尿病治療薬の世界市場：市場規模・現状・予測 Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels.In 2018, the global Non-insulin Diabetes Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end …
- 糖尿病薬物療法の世界市場：インサイト・予測 Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is …
- 世界のヒトインスリン薬及びデリバリーデバイス市場：動向・競争分析 Human insulin drugs and delivery devices are mainly used for injecting the insulin in the human body.The Human Insulin Drugs And Delivery Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, …